Temas de la conferencia Address Key European Regulatory Challenges and Cutting Edge Platform Design to Advance Allogeneic Approaches
Allogeneic therapies are fast becoming the holy grail for cell therapy as they boast the potential to reduce the cost of goods, improve accessibility, reduce turnaround times and have the ability to treat masses of patients.
